ProKidney Corp.(PROK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PROK ProKidney Corp.

Trading 07-27 15:08:02 EDT

1.56

+0.06

+4.00%

High1.61	Low1.52	Vol1.02M
Open1.53	D1 Closing1.50	Amplitude6.00%
Mkt Cap471.21M	Tradable Cap145.51M	Total Shares302.06M
T/O1.59M	T/O Rate1.09%	Tradable Shares93.27M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PROK","market":"US","secType":"STK","nameCN":"ProKidney Corp.","latestPrice":1.56,"timestamp":1785179281288,"preClose":1.5,"halted":0,"volume":1019059,"delay":0,"changeRate":0.040000000000000036,"floatShares":93273799,"shares":302059600,"eps":-0.525483,"marketStatus":"Trading","change":0.06,"latestTime":"07-27 15:08:02 EDT","open":1.53,"high":1.61,"low":1.52,"amount":1592463.8314613001,"amplitude":0.06,"askPrice":1.56,"askSize":4087,"bidPrice":1.55,"bidSize":6929,"shortable":3,"etf":0,"ttmEps":-0.525483,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1785182400000},"marketStatusCode":2,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":1.5,"preHourTrading":{"tag":"盘前","latestPrice":1.5,"preClose":1.5,"latestTime":"09:20 EDT","volume":83,"amount":124.71999149999999,"timestamp":1785158435106,"change":0,"changeRate":0,"amplitude":0.002667},"postHourTrading":{"tag":"盘后","latestPrice":1.47,"preClose":1.5,"latestTime":"19:34 EDT","volume":18484,"amount":27534.8452,"timestamp":1784936047443,"change":-0.03,"changeRate":-0.02,"amplitude":0.02},"volumeRatio":1.184649,"impliedVol":0.6933,"impliedVolPercentile":0.2231},"requestUrl":"/m/hq/s/PROK","defaultTab":"news","newsList":[{"id":"2649621057","title":"July 2026 Penny Stocks With Promising Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2649621057","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649621057?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:05","pubTimestamp":1783335935,"startTime":"0","endTime":"0","summary":"The market has climbed 1.6% in the last 7 days and is up 19% over the last 12 months, with earnings forecast to grow by 18% annually. For investors willing to explore beyond the big names, penny stocks — often smaller or newer companies — can be full of surprises. While the term might evoke earlier market trends, these stocks can provide a mix of affordability and growth potential when paired with strong financials.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prok/prokidney/news/july-2026-penny-stocks-with-promising-potential","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prok/prokidney/news/july-2026-penny-stocks-with-promising-potential","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SIGA","PROK","BK4102","BK4139","BK4007","BK4583","HFFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641447144","title":"Identiv And Two Other Penny Stocks To Watch Closely","url":"https://stock-news.laohu8.com/highlight/detail?id=2641447144","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641447144?lang=en_us&edition=fundamental","pubTime":"2026-06-06 01:15","pubTimestamp":1780679717,"startTime":"0","endTime":"0","summary":"The market remained flat over the last week, but it is up 26% over the past year, with earnings forecast to grow by 16% annually. For investors willing to look beyond the big names, penny stocks can present intriguing opportunities for growth at lower price points. While often associated with smaller or newer companies, these stocks can offer potential upside when backed by strong fundamentals and sound balance sheets.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prok/prokidney/news/identiv-and-two-other-penny-stocks-to-watch-closely","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prok/prokidney/news/identiv-and-two-other-penny-stocks-to-watch-closely","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4190","HERE","INVE","PROK","BK4157","BK4204","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640948847","title":"ProKidney names Kenneth Locke chief technical officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640948847","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640948847?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:06","pubTimestamp":1780402007,"startTime":"0","endTime":"0","summary":"ProKidney named Kenneth Locke as chief technical officer as it prepares for a pivotal topline readout for rilparencel in Q2 2027.Locke joins from Carisma Therapeutics, where he led CMC, quality, regulatory functions, and technical strategy for first-in-human CAR myeloid programs.He previously held cell-therapy manufacturing and supply-chain leadership roles at Celgene, now Bristol Myers Squibb, and at Novartis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prokidney Corp. published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL2kfWDB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0267386448.USD","BMY","IE00BFTCPJ56.SGD","LU0225284248.USD","LU0096364046.USD","LU0321505868.SGD","LU1868837300.USD","LU2360032135.SGD","LU1093756168.USD","BK4007","LU0985481810.HKD","IE00BFXG1179.USD","LU0868494617.USD","LU1670711123.USD","LU0432979614.USD","LU1670711040.USD","LU1883839398.USD","LU0061475181.USD","LU1074936037.SGD","LU1571399168.USD","CARM","LU2133065610.SGD","LU1983299246.USD","LU0225771236.USD","LU1430594728.SGD","LU0306806265.USD","BK4532","LU1670710588.SGD","LU1670710661.SGD","BK4534","BK4585","IE0002141913.USD","LU0306807586.USD","PROK","LU1323610961.USD","BK4559","LU1093756325.SGD","LU2242646821.SGD","BK4139","LU0237698245.USD","LU2242652126.USD","IE00B2B36J28.USD","LU0321505439.SGD","LU1585245621.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1291159041.SGD","LU1868836914.USD","LU1868836757.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640104079","title":"ProKidney Appoints Kenneth Locke as Chief Technical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640104079","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640104079?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:00","pubTimestamp":1780401605,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUA5GV5FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PROK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672427","title":"ProKidney shareholders elect directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672427","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672427?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:03","pubTimestamp":1780085008,"startTime":"0","endTime":"0","summary":"ProKidney held its annual shareholder meeting on May 28, 2026.Shareholders backed the selection of three director nominees to serve three-year terms running to the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prokidney Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDLbJqLBg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PROK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636952072","title":"ProKidney Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2636952072","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636952072?lang=en_us&edition=fundamental","pubTime":"2026-05-18 23:09","pubTimestamp":1779116940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PROK/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 18, 2026 11:09 ET (15:09 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PROK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636191480","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Insulet (PODD), ProKidney (PROK) and CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636191480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636191480?lang=en_us&edition=fundamental","pubTime":"2026-05-18 05:10","pubTimestamp":1779052219,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Insulet (PODD), ProKidney (PROK) and CG Oncology, Inc. (CGON). In...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-insulet-podd-prokidney-prok-and-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-insulet-podd-prokidney-prok-and-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","LABU","XBI","IE00B64PRP62.GBP","BK4581","BK4139","BK4588","BK4551","IE00B3QW5Z07.USD","PODD","LU2065170008.USD","CGON","LU0029874061.USD","LU2065171402.SGD","XLV","BK4585","LU2324357040.USD","LU1084165304.USD","LU1119994496.HKD","IE00BGHQF748.EUR","BK4566","PROK","LU2065171311.SGD","LU0128526141.USD","LU0728928796.USD","BK4082","LU2065169927.USD","HCSG","LU1261432733.SGD","BK4135","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635039240","title":"Prokidney Corp reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635039240","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635039240?lang=en_us&edition=fundamental","pubTime":"2026-05-16 01:02","pubTimestamp":1778864550,"startTime":"0","endTime":"0","summary":"Prokidney Corp reports results for the quarter ended March 31 - Earnings SummaryProkidney Corp PROK.OQ reported a quarterly adjusted loss of 14 cents per share for the quarter ended March 31, lower th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL8N41S1VI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PROK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635036301","title":"ProKidney Q1 loss widens as R&D spending rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2635036301","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635036301?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:55","pubTimestamp":1778860550,"startTime":"0","endTime":"0","summary":"ProKidney Q1 loss widens as R&D spending risesOverviewU.S. cell therapy developer posted Q1 net loss of $42.6 mln, EPS loss of $0.14R&D expenses rose on higher clinical and manufacturing costs for Pha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL1N41S0TE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PROK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035272","title":"ProKidney Q1 EPS $(0.14), Inline, Sales $226.000K Beat $143.667K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035272","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635035272?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:46","pubTimestamp":1778859988,"startTime":"0","endTime":"0","summary":"ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 7.69 percent decrease over losses of $(0.13) per share from the same period last year.  The","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://www.benzinga.com/news/earnings/26/05/52604253/prokidney-q1-eps-0-14-inline-sales-226-000k-beat-143-667k-estimate","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52604253/prokidney-q1-eps-0-14-inline-sales-226-000k-beat-143-667k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635363250","title":"BRIEF-ProKidney Q1 Operating Income USD -44.933 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635363250","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635363250?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:45","pubTimestamp":1778859945,"startTime":"0","endTime":"0","summary":"BRIEF-ProKidney Q1 Operating Income USD -44.933 Million\n\n\nMay 15 (Reuters) - ProKidney Q1 pretax profit USD -42.621 million.\n\nQ1 operating expenses USD 45.159 million\nQ1 EPS USD -0.14","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nPLX7B23F2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035082","title":"ProKidney Reports First Quarter 2026 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035082","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635035082?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:45","pubTimestamp":1778859901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUA5SBBHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PROK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635707035","title":"ProKidney Q1 Pretax Profit USD -42.621 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635707035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635707035?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:45","pubTimestamp":1778859900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nPLX7B23F2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PROK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035080","title":"ProKidney Q1 EPS USD -0.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635035080?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:45","pubTimestamp":1778859900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nPLX7B23F2:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PROK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035038","title":"ProKidney Q1 Operating Expenses USD 45.159 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635035038?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:45","pubTimestamp":1778859900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nPLX7B23F2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PROK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634464941","title":"Prokidney Corp  expected to post a loss of 14 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634464941","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634464941?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:07","pubTimestamp":1778270825,"startTime":"0","endTime":"0","summary":"Prokidney Corp  expected to post a loss of14cents a share - Earnings Preview Prokidney Corp PROK.OQ PROK.O is expected to  show a fall in quarterly revenue when it reports  results on May 11 (estimate","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2JD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628781285","title":"ProKidney announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628781285","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628781285?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:06","pubTimestamp":1776456419,"startTime":"0","endTime":"0","summary":"ProKidney schedules annual shareholder meeting in Boston on May 28, 2026.Shareholders will vote to elect three Class I directors for terms expiring at 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prokidney Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL6kBsZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622075004","title":"ProKidney appoints Greg Madison as chief commercial officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2622075004","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622075004?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:05","pubTimestamp":1774469132,"startTime":"0","endTime":"0","summary":"ProKidney (PROK) announced the appointment of Greg Madison as chief commercial officer. In this role, Madison will drive ProKidney’s commercial str...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prokidney-appoints-greg-madison-as-chief-commercial-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prokidney-appoints-greg-madison-as-chief-commercial-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PROK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622004340","title":"BRIEF-Prokidney Expands Senior Leadership Team With Appointment Of Greg Madison As Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2622004340","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622004340?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:02","pubTimestamp":1774468979,"startTime":"0","endTime":"0","summary":"BRIEF-Prokidney Expands Senior Leadership Team With Appointment Of Greg Madison As Chief Commercial OfficerMarch 25 (Reuters) - Prokidney Corp PROK.O:PROKIDNEY EXPANDS SENIOR LEADERSHIP TEAM WITH APPO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nTUA3DHCJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622004356","title":"Press Release: ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2622004356","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622004356?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:01","pubTimestamp":1774468860,"startTime":"0","endTime":"0","summary":"WINSTON-SALEM, N.C., March 25, 2026  -- ProKidney Corp.  , a leading late clinical-stage cell therapy company focused on chronic kidney disease , today announced the appointment of Greg Madison as Chief Commercial Officer. In this role, Mr. Madison will drive ProKidney's commercial strategy as the Company advances towards the potential commercialization of rilparencel.\"ProKidney is developing a truly novel cell therapy with the potential to address a profound unmet need for patients with advanced CKD and diabetes,\" said Greg Madison. \"As a potential first cell therapy for CKD patients and nephrologists, I am excited to join the Company at such an important time. I look forward to working alongside Bruce and the broader team to shape the commercial strategy, organization, and execute the plans needed to support the potential launch of rilparencel.\". CKD is a progressive condition characterized by the gradual decline of kidney function, which can ultimately lead to end-stage kidney di","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","R","TISI","BK4120","BK4139","BK4232","PROK"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prokidney.com","stockEarnings":[{"period":"1week","weight":-0.0741},{"period":"1month","weight":-0.1525},{"period":"3month","weight":-0.2268},{"period":"6month","weight":-0.3088},{"period":"1year","weight":-0.5399},{"period":"ytd","weight":-0.3304}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.022112},{"month":2,"riseRate":0.8,"avgChangeRate":0.049183},{"month":3,"riseRate":0.4,"avgChangeRate":-0.102405},{"month":4,"riseRate":0.6,"avgChangeRate":0.032646},{"month":5,"riseRate":0.6,"avgChangeRate":0.15052},{"month":6,"riseRate":0.4,"avgChangeRate":-0.086475},{"month":7,"riseRate":0.333333,"avgChangeRate":0.578945},{"month":8,"riseRate":0.2,"avgChangeRate":-0.09753},{"month":9,"riseRate":0.4,"avgChangeRate":-0.139421},{"month":10,"riseRate":0.6,"avgChangeRate":-0.082174},{"month":11,"riseRate":0.4,"avgChangeRate":-0.019735},{"month":12,"riseRate":0.6,"avgChangeRate":-0.066082}],"exchange":"NASDAQ","name":"ProKidney Corp.","nameEN":"ProKidney Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProKidney Corp.(PROK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ProKidney Corp.(PROK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ProKidney Corp.,PROK,ProKidney Corp.股票,ProKidney Corp.股票老虎,ProKidney Corp.股票老虎国际,ProKidney Corp.行情,ProKidney Corp.股票行情,ProKidney Corp.股价,ProKidney Corp.股市,ProKidney Corp.股票价格,ProKidney Corp.股票交易,ProKidney Corp.股票购买,ProKidney Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProKidney Corp.(PROK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ProKidney Corp.(PROK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction